NEW YORK, March 19, 2018 — AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced financial results for the quarter and year ended December 31, 2017, and provided an overview of recent operational highlights. Read More
The post AXIM Biotechnologies Reports Year End 2017 Results appeared first on Dagga Magazine.